VanEck ETF Trust VanEck Consumer Discretionary TruSector ETF TRUD 深 滬
等待開盤 10-04 09:30:00 美东时间
25.7846
-0.230
-0.89%
華盛通- 最 高25.9253
- 今 開25.9253
- 成交量 358股
- 最 低 25.7846
- 昨 收 26.015
- 總市值 51.57万
- 52周最高 26.4779
- 市盈率 靜 --
- 換手率 1.79%
- 52周最低 24.545
- 委 比 0.00%
- 總股本 2.00万
- 歷史最高 26.4779
- 量 比 0.24
- 振 幅 0.54%
- 歷史最低 24.545
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Merck's Keytruda Gets Green Light For New Head And Neck Cancer Use, European Approval Decision Due This Year
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted two positive opinions for
09-19 18:48
Eli Lilly's Olomorasib + KEYTRUDA Combo Secures FDA Breakthrough Therapy Designation For KRAS G12C NSCLC With High PD-L1
The Breakthrough Therapy designation for olomorasib is based on data from the Phase 1/2 LOXO-RAS-20001 trial and Phase 3 SUNRAY-01 trialUpdated efficacy and safety data for olomorasib will be presented at the IASLC 2025
09-04 18:50
VanEck Targets Nvidia, Microsoft Weight Caps With TruSector ETFs For Tech, Consumer Sectors
VanEck has new ETFs that aim to minimize tracking error by eliminating artificial limits on leading holdings.
08-26 21:17
HCW Biologics Shares Soar On Breakthrough Second-Generation Cancer Immunotherapy
HCW Biologics Inc. (NASDAQ: HCWB) shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors.
08-26 04:32
